Patents by Inventor Eugene TEOH

Eugene TEOH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMAGING OF BRAIN LESIONS
    Publication number: 20260076634
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing, and monitoring of brain lesions.
    Type: Application
    Filed: September 17, 2025
    Publication date: March 19, 2026
    Applicant: Blue Earth Diagnostics Limited
    Inventors: Eugene Teoh, Robin Holmes, Sharon Weick
  • Imaging of metastatic or recurrent cancer
    Patent number: 11980674
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Grant
    Filed: June 17, 2021
    Date of Patent: May 14, 2024
    Assignee: Blue Earth Diagnostics Limited
    Inventors: Eugene Teoh, Matthew Miller, Peter Gardiner
  • IMAGING OF MYELOMA BONE LESIONS
    Publication number: 20230218255
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC for imaging, diagnosing, and/or monitoring of myeloma bone lesions.
    Type: Application
    Filed: January 6, 2023
    Publication date: July 13, 2023
    Applicant: Blue Earth Diagnostics Limited
    Inventor: Eugene TEOH
  • IMAGING OF BRAIN LESIONS
    Publication number: 20230126453
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing, and monitoring of brain lesions.
    Type: Application
    Filed: October 22, 2021
    Publication date: April 27, 2023
    Applicant: Blue Earth Diagnostics Limited
    Inventor: Eugene TEOH
  • IMAGING OF METASTATIC OR RECURRENT CANCER
    Publication number: 20210393808
    Abstract: The present disclosure relates to methods of administering [18F]-FACBC. The present disclosure also relates to use of [18F]-FACBC in methods for imaging, diagnosing and monitoring metastasis or recurrence of cancer.
    Type: Application
    Filed: June 17, 2021
    Publication date: December 23, 2021
    Applicant: Blue Earth Diagnostics Limited
    Inventors: Eugene TEOH, Matthew MILLER, Peter GARDINER